Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles

Published:2014-03 Issue: Volume:74 Page:606-618
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Vitale Paola,Perrone Maria Grazia,Malerba Paola,Lavecchia Antonio,Scilimati Antonio

Funder

Ministero dell'Istruzione dell'Università e della Ricerca

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference64 articles.

1. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs;Vane;Nature New Biol.,1971

2. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition;Simmons;Pharmacol. Rev.,2004

3. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities;Grosser;J. Clin. Invest.,2006

4. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects;Patrignani;J. Clin. Invest.,1982

5. The coxibs, selective inhibitors of cyclooxygenase-2;Fitzgerald;N. Engl. J. Med.,2001

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, molecular dynamics simulation, and evaluation of biological activity of novel flurbiprofen and ibuprofen‐like compounds;Journal of Molecular Recognition;2024-06-18

2. Synthesis, Docking, and DFT Studies on Novel Schiff Base Sulfonamide Analogues as Selective COX-1 Inhibitors with Anti-Platelet Aggregation Activity;Pharmaceuticals;2024-05-30

3. A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior;European Journal of Medicinal Chemistry;2024-02

4. m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity;Molecules;2023-07-13

5. SC‐560 and mofezolac isosteres as new potent COX‐1 selective inhibitors with antiplatelet effect;Archiv der Pharmazie;2023-02-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3